Finance

Lists
HYPE3:BVMF
Hypera SA
26,00 R$
0,00%
(0,00) 1D
13 ოქტ, 17:05:45 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for HYPE3...
Open
26,52 R$
High
26,71 R$
Low
25,70 R$
Mkt. cap
18,30 მლრდ.
Avg. vol.
3,93 მლნ.
Volume
6,12 მლნ.
Dividend
3,69%
Quarterly dividend
0,24 R$
Ex-dividend date
9 თებ. 2026
P/E ratio
9,79
52-wk high
30,00 R$
52-wk low
19,43 R$
EPS
2,66 R$
Shares outstanding
704,01 მლნ.
No. of employees
11 ათ.
Open
26,52 R$
High
26,71 R$
Low
25,70 R$
Mkt. cap
18,30 მლრდ.
Avg. vol.
3,93 მლნ.
Volume
6,12 მლნ.
Dividend
3,69%
Quarterly dividend
0,24 R$
Ex-dividend date
9 თებ. 2026
P/E ratio
9,79
52-wk high
30,00 R$
52-wk low
19,43 R$
EPS
2,66 R$
Shares outstanding
704,01 მლნ.
No. of employees
11 ათ.
News stories
From web sources and news partners
Profile
Hypera Pharma is a Brazilian multinational pharmaceutical company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
About Hypera SA
CEO-
Employees10,6 ათ.
Founded2001
HeadquartersItaim Bibi, სან-პაულუს შტატი, ბრაზილია
SectorPharmaceutical industry
Last report
7 აგვ. 2026
Fiscal period
Q2 2026
0,70 R$ / 0,70 R$
-0,54%miss
Revenue / Est. (BRL)
2,34 მლრდ. / 2,33 მლრდ.
+0,28%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,23 მლრდ.
2,24 მლრდ.
2,02 მლრდ.
2,34 მლრდ.
Cost of goods sold
865,21 მლნ.
858,94 მლნ.
807,22 მლნ.
892,99 მლნ.
Cost of revenue
865,21 მლნ.
858,94 მლნ.
807,22 მლნ.
892,99 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
687,46 მლნ.
728,46 მლნ.
703,28 მლნ.
780,69 მლნ.
Operating expense
688,45 მლნ.
728,74 მლნ.
701,06 მლნ.
773,84 მლნ.
Total operating expenses
1,55 მლრდ.
1,59 მლრდ.
1,51 მლრდ.
1,67 მლრდ.
Operating income
673,59 მლნ.
649,38 მლნ.
509,50 მლნ.
669,87 მლნ.
Other non operating income
-14,67 მლნ.
-27,28 მლნ.
-8,73 მლნ.
-30,17 მლნ.
EBT including unusual items
448,11 მლნ.
439,21 მლნ.
276,14 მლნ.
492,29 მლნ.
EBT excluding unusual items
452,42 მლნ.
438,30 მლნ.
279,75 მლნ.
488,66 მლნ.
Income tax expense
-5,77 მლნ.
-10,46 მლნ.
-69,54 მლნ.
2,28 მლნ.
Effective tax rate
-1,29%
-2,38%
-25,18%
0,46%
Other operating expenses
987,00 ათ.
283,00 ათ.
-2,21 მლნ.
-6,84 მლნ.
Net income
457,64 მლნ.
450,99 მლნ.
347,38 მლნ.
490,24 მლნ.
Net profit margin
20,55%
20,16%
17,22%
20,98%
Earnings per share
0,72
0,71
0,55
0,70
Interest and investment income
69,23 მლნ.
68,87 მლნ.
64,66 მლნ.
63,02 მლნ.
Interest expense
-283,65 მლნ.
-268,84 მლნ.
-282,34 მლნ.
-209,57 მლნ.
Net interest expenses
-214,42 მლნ.
-199,97 მლნ.
-217,68 მლნ.
-146,55 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
728,99 მლნ.
702,34 მლნ.
562,68 მლნ.
755,79 მლნ.
Gain or loss from assets sale
-11,00 ათ.
-253,00 ათ.
-3,20 მლნ.
-698,00 ათ.
AI content may include mistakes. Learn more
Google აპები